Prevention of dementia in patients with mild cognitive impairment

Zaharov V.V.; Novikova M.S.; Vakhnina N.V.

doi:https://doi.org/10.17116/jnevro2020120081167

Close metadata

Recommended articles:

Curcumin-induced increased retinal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):19-25

Differential diagnosis of Alzheimer’s disease and vascular cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35

Change of subjective cognitive decline in first-degree relatives of patients with Alzheimer’s disease: results of a 15-year prospective study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):36-42

Structural features of the brain in amnestic mild cognitive impairment and their correlation with mild behavioral impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):112-119

Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):86-99

The patient pathway in the diagnosis and treatment of mild cognitive impairment and new therapeutic opportunities. Resolution of the Expert Council (Moscow, April 21, 2025). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):100-104

Obstructive sleep apnea as an aggravating factor of cognitive impairment in vascular cognitive disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):151-156

Cognitive rehabilitation technology using a combination of postural training and simultaneous cognitive task in prevention of cognitive impairment after coronary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):418-427

Free radicals in reproductive processes. Russian Journal of Human Reproduction. 2025;(5):51-57

Abstract:

Cognitive impairment is one of the most common consequences of brain dysfunction. Nowadays, there is an increasing interest in the diagnosis and treatment of cognitive impairment without dementia, as a stage of cognitive deficit spectrum that could be controlled. The article discusses the current approaches to the management of patients with mild cognitive impairment including non-pharmacological strategies as well as medical antioxidant treatment.

Keywords:

mild cognitive impairment

prevention of dementia

cognitive training

antioxidants

Authors:

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

SPIN RSCI: 6404-1030
Scopus AuthorID: 7402991374
ORCID: 0000-0002-8447-3264

Novikova M.S.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-8382-6366

Vakhnina N.V.

Sechenov First Moscow State Medical University

ORCID: 0000-0002-0834-4030

Received:

05.06.2020

Accepted:

13.07.2020

Close metadata

References:

US Preventive Services Task Force Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng C-W, John B, Wong JB. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323:8(2020):757-763. https://doi.org/10.1001/jama.2020.0435
Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer Report 2015 The Global Impact of Dementia [Electronic resource]. https://www.alz.co.uk/research/world-report-2015
Gaugler J, James B, Johnson T, Marin A, Weuve J. Alzheimer’s disease facts and figures. Alzheimers Dement. 2019;15:321-387.
Yahno NN, Zaharov VV, Lokshina AB, Koberskaya NN, Mhitaryan EA. Demencii. Ruk-vo dlya vrachej. 2-e izd. M.: Medpress-inform; 2010. (In Russ.).
Yahno NN. Cognitive impairment in neurological clinical practice. Nevrologicheskij Zhurnal. 2006;11(1):4-12. (In Russ.).
Zaharov VV, Kabaeva AR. Non-demented cognitive impairment: subjective, mild case or moderate. Nervnye Bolezni. 2017;4:3-9. (In Russ.).
Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild Cognitive Impairment: Long-Term Course of Four Clinical Subtypes. Neurology. 2006;67:12:2176-2185. https://doi.org/10.1212/01.wnl.0000249117.23318.e1
US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng C-W, Wong JB. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(8):757-763. https://doi.org/10.1001/jama.2020.0435
Das SK, Bose P, Biswas A, Dutt A, Banerjee TK, Hazra A, Raut DK, Chaudhuri A, Roy T. An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology. 2007;68:2019-2026.
Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues J-F, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008;79(9):979‐984. https://doi.org/10.1136/jnnp.2007.136903
Coj RT, Turuspekova ST, Klipickaya NK. Modern state of the problem of the prevalence of mild cognitive impairment and dementia. Nejrohirurgiya i Nevrologiya Kazahstana. 2018;1(50):47-53. (In Russ.).
Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718-726. https://doi.org/10.1016/j.jalz.2015.05.016
Zaharov VV. Medicinal and non-medicinal methods of correction of cognitive violations. Consilium Medicum. 2014;16:2:24-29. (In Russ.).
Preobrazhenskaya IS, Fantalis D, Abdyshova SA, Kindarova AA. Non-drug therapies for cognitive impairment. Nevrologiya, Nejropsihiatriya, Psihosomatika. 2019;11(3):68-77. (In Russ.).
Ruan Y, Tang J, Guo X, Li K, Li D. Dietary Fat Intake and Risk of Alzheimer’s Disease and Dementia: A Meta-Analysis of Cohort Studies. Curr Alzheimer Res. 2018;15(9):869‐876. https://doi.org/10.2174/1567205015666180427142350
Morris MC, Tangney CC. Dietary fat composition and dementia risk. Neurobiol Aging. 2014;35(suppl 2):59-64. https://doi.org/10.1016/j.neurobiolaging.2014.03.038
Wong WB, Lin VW, Boudreau D, Devine EB. Statins in the prevention of dementia and Alzheimer’s disease: a meta-analysis of observational studies and an assessment of confounding Pharmacoepidemiol. Drug Saf. 2013;22:345-358.
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review [published correction appears in Lancet Neurol. 2006;5(2):113. Lancet Neurol. 2006;5(1):64‐74. https://doi.org/10.1016/S1474-4422(05)70284-2
Pitsavos C, Panagiotakos DB, Tzima N, Chrysohoou C, Economou M, Zampelas A, Stefanadis C. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am J Clin Nutr. 2005;82(3):694‐699. https://doi.org/10.1093/ajcn.82.3.694
Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO. Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271-282. https://doi.org/10.3233/JAD-130830
Martínez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, Julián BS, Sanchez-Tainta A, Ros E, Valls-Pedret C, Martinez-Gonzalez MA. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84(12):1318-1325. https://doi.org/10.1136/jnnp-2012-304792
Bo Y, Zhang X, Wang Y, You J, Cui H, Zhu Y, Pang W, Liu W, Jiang Y, Lu Q. The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial. Nutrients. 2017;9(1):54. Published 2017 Jan 10. https://doi.org/10.3390/nu9010054
Solfrizzi V, Agosti P, Lozupone M, Custodero C, Schilardi A, Valiani V, Santamato A, Sardone R, Dibello V, Lena LD, Stallone R, Ranieri M, Bellomo A, Greco A, Daniele A, Seripa D, Sabbà C, Logroscino G, Francesco Panza F. Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review [published correction appears in Neurosci Biobehav Rev. 2020;108:889]. Neurosci Biobehav Rev. 2018;95:480-498.
Anastasiou CA, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Arampatzi X, Bougea A, Labropoulos I, Scarmeas N. Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PLoS One. 2017;12(8):e0182048. Published 2017 Aug 1. https://doi.org/10.1371/journal.pone.0182048
Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015;11(9):1007-1014. https://doi.org/10.1016/j.jalz.2014.11.009
McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, Stover AN, Krikorian R. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-156. https://doi.org/10.1016/j.neurobiolaging.2017.12.003
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Martínez-González MA. Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med. 2013;368:1279-1290 [retraction of: N Engl J Med. 2013;368(14):1279-1290]. N Engl J Med. 2018;378(25):2441‐2442. https://doi.org/10.1056/NEJMc1806491
Pitsavos C, Panagiotakos DB, Tzima N, Chrysohoou C, Economou M, Zampelas A, Stefanadis C. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am J Clin Nutr. 2005;82(3):694-699.
Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A. Diet and Alzheimer’s disease risk factors or prevention: The current evidence. Expert Review of Neurotherapeutics. 2011;11(5):677-708. https://doi.org/10.1586/ern.11.56
Arenaza-Urquijo EM, de Flores R, Gonneaud J, Wirth M, Ourry V, Callewaert W, Landeau B, Egret S, Mézenge F, Desgranges B, Chételat G. Distinct effects of late adulthood cognitive and physical activities on gray matter volume. Brain Imaging Behav. 2017;11(2):346-356. https://doi.org/10.1007/s11682-016-9617-3
Panza GA, Taylor BA, MacDonald HV, Johnson BT, Zaleski AL, Livingston J, Thompson PD, Pescatello LS. Can Exercise Improve Cognitive Symptoms of Alzheimer’s Disease? J Am Geriatr Soc. 2018;66(3):487-495. https://doi.org/10.1111/jgs.15241
Robinson MM, Lowe VJ, Nair KS. Increased Brain Glucose Uptake After 12 Weeks of Aerobic High-Intensity Interval Training in Young and Older Adults. J Clin Endocrinol Metab. 2018;103(1):221-227. https://doi.org/10.1210/jc.2017-01571
Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, Gach HM, Thompson PM, Ho AJ, Kuller LH. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology. 2010;75(16):1415-1422. https://doi.org/10.1212/WNL.0b013e3181f88359
Alfini AJ, Weiss LR, Nielson KA, Verber MD, Smith JC. Resting Cerebral Blood Flow After Exercise Training in Mild Cognitive Impairment. J Alzheimers Dis. 2019;67(2):671-684. https://doi.org/10.3233/JAD-180728
Liu-Ambrose T, Best JR, Davis JC, Eng JJ, Lee PE, Jacova C, Boyd LA, Brasher PM, Munkacsy M, Cheung W, Hsiung GR. Aerobic exercise and vascular cognitive impairment: A randomized controlled trial. Neurology. 2016;87(20):2082-2090. https://doi.org/10.1212/WNL.0000000000003332
Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Ito K, Shimokata H, Washimi Y, Endo H, Kato T. A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PloS One vol. 2013;8,4 e61483. https://doi.org/10.1371/journal.pone.0061483
Bademli K, Lok N, Canbaz M, Lok S. Effects of Physical Activity Program on cognitive function and sleep quality in elderly with mild cognitive impairment: A randomized controlled trial. Perspect Psychiatr Care. 2019;55(3):401-408. https://doi.org/10.1111/ppc.12324
Flöel A, Ruscheweyh R, Krüger K, Willemer C, Winter B, Völker K, Lohmann H, Zitzmann M, Mooren F, Breitenstein C, Knecht S. Physical activity and memory functions: are neurotrophins and cerebral gray matter volume the missing link? Neuroimage. 2010;49:2756-2763.
Merritt JR, Rhodes JS. Mouse genetic differences in voluntary wheel running, adult hippocampal neurogenesis and learning on the multi-strain-adapted plus water maze. Behav Brain Res. 2015;280:62-71. https://doi.org/10.1016/j.bbr.2014.11.030
Rodakowski J, Saghafi E, Butters MA, Skidmore ER. Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review. Mol Aspects Med. 2015;43-44:38-53. https://doi.org/10.1016/j.mam.2015.06.003
Johnston MV. Plasticity in the Developing Brain: Implications for Rehabilitation. Developmental Disabilities Research Reviews. 2009;15:2:94-101. https://doi.org/10.1002/ddrr.64
Hahn C, Lee CU. A Brief Review of Paradigm Shifts in Prevention of Alzheimer’s Disease: From Cognitive Reserve to Precision Medicine [published correction appears in Front Psychiatry. 2019 Dec 17;10:900]. Front Psychiatry. 2019;10:786. Published 2019 Oct 31. https://doi.org/10.3389/fpsyt.2019.00786
Kueider AM, Parisi JM, Gross AL, Rebok GW. Computerized cognitive training with older adults: a systematic review. PLoS One. 2012;7(7):e40588. https://doi.org/10.1371/journal.pone.0040588
Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues J-F, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008;79(9):979‐984. https://doi.org/10.1136/jnnp.2007.136903
Bubbico G, Chiacchiaretta P, Parenti M, di Marco M, Panara V, Sepede G, Ferretti A, Perrucci MG. Effects of Second Language Learning on the Plastic Aging Brain: Functional Connectivity, Cognitive Decline, and Reorganization. Front Neurosci. 2019;13:423. Published 2019 May 15. https://doi.org/10.3389/fnins.2019.00423
Bialystok E, Craik FI, Freedman M. Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia. 2007;45(2):459‐464. https://doi.org/10.1016/j.neuropsychologia.2006.10.009
Chertkow H, Whitehead V, Phillips N, Wolfson C, Atherton J, Bergman H. Multilingualism (but not always bilingualism) delays the onset of Alzheimer disease: evidence from a bilingual community. Alzheimer Dis Assoc Disord. 2010;24(2):118‐125. https://doi.org/10.1097/WAD.0b013e3181ca1221
Guzmán-Vélez E, Tranel D. Does bilingualism contribute to cognitive reserve? Cognitive and neural perspectives. Neuropsychology. 2015;29(1):139‐150. https://doi.org/10.1037/neu0000105
Djabelkhir L, Wu YH, Vidal JS, Cristancho-Lacroix V, Marlats F, Lenoir H, Carno A, Rigaud A-S. Computerized cognitive stimulation and engagement programs in older adults with mild cognitive impairment: comparing feasibility, acceptability, and cognitive and psychosocial effects. Clin Interv Aging. 2017;12:1967-1975. Published 2017 Nov 21. https://doi.org/10.2147/CIA.S145769
Savulich G, Piercy T, Fox C, Suckling J, Rowe JB, O’Brien JT, Sahakian BJ. Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI). Int J Neuropsychopharmacol. 2017;20(8):624-633. https://doi.org/10.1093/ijnp/pyx040
Li BY, He NY, Qiao Y, Xu H-M, Lu Y-Z, Cui P-J, Ling H-W, Yan F-H, Tang H-D, Chen S-D. Computerized cognitive training for Chinese mild cognitive impairment patients: A neuropsychological and fMRI study. Neuroimage Clin. 2019;22:101691. https://doi.org/10.1016/j.nicl.2019.101691
Zhao J, Li H, Lin R, Wei Y, Yang A. Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial. Clin Interv Aging. 2018;13:1313-1320. Published 2018 Jul 24. https://doi.org/10.2147/CIA.S161861
Park J, Kim SE, Kim EJ, Lee BI, Jeong JH, Na HR, Choi SH, Kang D-Y, Park KW. Effect of 12-week home-based cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment. Clin Interv Aging. 2019;14:1167-1175. Published 2019 Jun 28. https://doi.org/10.2147/CIA.S200269
Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger KJ. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer’s disease: a pilot study. Alzheimers Dis. 2011;25(4):679-694.
Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y, Uemura K, Lee S, Park H. Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial. BMC Neurol. 2012;12:128. Published 2012 Oct 31. https://doi.org/10.1186/1471-2377-12-128
Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2016;131:226‐238. https://doi.org/10.1016/j.neuroimage.2015.09.050
Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255-2263. https://doi.org/10.1016/S0140-6736(15)60461-5
Vahnina NV. Vascular cognitive impairment. Nevrologiya, Nejropsihiatriya, Psihosomatika. 2014;1:74-79. (In Russ.).
Kadykov AS, Shahparonova NV. Prospects of neuroprotective therapy in the treatment of cognitive disorders. Consilium Medicum. 2007;9:12:72-75. (In Russ.).
Hasanova DR, Zhitkova YuV, Yakusheva LM. Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments. Zhurnal Nevrologiya, Nejropsihiatriya, Psihosomatika. 2014;114(5):22-27. (In Russ.).
Sernov LN. New domestic antioxidant of the second generation. Lekarstvennye Preparaty i Racional’naya Farmakoterapiya. 2013;3:4-7. (In Russ.).
Goroshko OA, Novikov KN, Kukes VG, Voejkov VL, Arhipov VV, Buravleva EV, Berdnikova NG, Zhestovskaya AS. Correction of oxidative stress in patients with chronic cerebral ischemia. Klinicheskaya Medicina. 2016;94(7):549-553. (In Russ.).
Dadasheva MN, Taranenko NY, Agafonov BV, Chudakov SY. Pathogenetic therapy with a new domestic antioxidant Ethoxidol in cerebrovascular disease. Vestnik Semejnoj Mediciny. 2015;1-2:12-18. (In Russ.).